GPC
37
2
CMI
64
5
LRCX
45
6
WU
30
6
AN
54
4
WDC
43
2
ADP
66
2
KMI
69
2
KLAC
43
4
CTSH
54
-2
NAVI
47
3
AON
52
2
HPQ
57
-2
SO
57
2
LMT
32
-12
CMS
60
2
ROK
47
-8
CPB
24
2
JNJ
44
3
DG
4
2
GPC
37
2
CMI
64
5
LRCX
45
6
WU
30
6
AN
54
4
WDC
43
2
ADP
66
2
KMI
69
2
KLAC
43
4
CTSH
54
-2
NAVI
47
3
AON
52
2
HPQ
57
-2
SO
57
2
LMT
32
-12
CMS
60
2
ROK
47
-8
CPB
24
2
JNJ
44
3
DG
4
2
Financhill
Back

Protagonist Therapeutics Vs. Kyndryl Holdings Industry Stock Comparison

Sell
33

PTGX
Protagonist Therapeutics

Last Price:
46.45
Seasonality Move:
11.46%
Sell
22

KD
Kyndryl Holdings

Last Price:
33.07
Seasonality Move:
21.65%
Sell
33
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $41.65. The Score for PTGX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Kyndryl Holdings (KD) is a Sell

Is Kyndryl Holdings a Buy, Sell or Hold?

  • The current Kyndryl Holdings [KD] share price is $32.49. The Score for KD is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • KD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $41.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight selling pressure.

KD Stock Price Chart

What is Kyndryl Holdings's stock price today?

  • The Kyndryl Holdings share price today is $32.49
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KD is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 41.01 Sell
Chaikin Money Flow: -281616 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.23 - 47.93) Sell
Bollinger Bands (100): (38.1 - 46.24) Sell

KD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.52 Buy
Relative Strength Index (14 RSI): 83.94 Buy
Chaikin Money Flow: 4050180 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.38 - 28.4) Buy
Bollinger Bands (100): (22.65 - 26.71) Buy

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.17 Buy
20-day SMA: 44.7 Sell
50-day SMA: 45.23 Sell
200-day SMA: 35.68 Buy
8-day EMA: 41.66 Sell
20-day EMA: 43.5 Sell
50-day EMA: 43.92 Sell
200-day EMA: 36.78 Buy

KD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.77 Buy
20-day SMA: 26.27 Buy
50-day SMA: 24.78 Buy
200-day SMA: 23.96 Buy
8-day EMA: 28.86 Buy
20-day EMA: 27.1 Buy
50-day EMA: 25.54 Buy
200-day EMA: 23.47 Buy

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.

Kyndryl Holdings Earnings Growth & KD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $1.26 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kyndryl Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):